Vamorolone Side Effects
Medically reviewed by Drugs.com. Last updated on Nov 10, 2024.
Applies to vamorolone: oral suspension.
Side effects include:
Most common adverse reactions (>10%): cushingoid features, psychiatric disorders, vomiting, increased weight, vitamin D deficiency.
For healthcare professionals
Applies to vamorolone: oral suspension.
General adverse events
The most common adverse reactions occurring in greater than 10% of treated patients included cushingoid features, psychiatric disorders, vomiting, increased weight, and vitamin D deficiency.[Ref]
Cardiovascular
- Frequency not reported: Thromboembolic events, elevated blood pressure
Endocrine
- Very common (10% or more): Cushingoid features (up to 29%)
- Frequency not reported: Pheochromocytoma crisis, increased blood glucose, Cushing's syndrome (hypercortisolism), acute adrenal insufficiency (after abrupt withdrawal)
Gastrointestinal
- Very common (10% or more): Vomiting (up to 17%)
- Common (1% to 10%): Diarrhea
- Frequency not reported: Gastrointestinal perforation
Hematologic
- Frequency not reported: Increased lymphocyte and neutrophil counts
Hypersensitivity
- Frequency not reported: Anaphylaxis
Immunologic
- Frequency not reported: Reduced resistance to new infections
Metabolic
- Very common (10% or more): Increased weight (up to 11%), vitamin D deficiency (up to 11%)
- Common (1% to 10%): Increased appetite
- Frequency not reported: Increased excretion of potassium and calcium, salt and water retention
Musculoskeletal
- Frequency not reported: Avascular necrosis, decreased bone formation, increased bone resorption
Nervous system
- Common (1% to 10%): Headache
Ocular
- Frequency not reported: Posterior subcapsular cataracts
Oncologic
- Frequency not reported: Kaposi's sarcoma
Other
- Frequency not reported: Activation of latent amebiasis, exacerbation of systemic fungal infections, hepatitis B virus reactivation
Psychiatric
- Very common (10% or more): Psychiatric disorders (up to 21%)
Psychiatric disorders included abnormal behavior, aggression, agitation, anxiety, irritability, mood altered, sleep disorder, and stereotypy.
Respiratory
- Very common (10% or more): Cough (up to 10%)
- Common (1% to 10%): Rhinitis
See also:
Amondys 45
Amondys 45 (casimersen) is used to treat Duchenne muscular dystrophy (DMD) with a genetic mutation ...
Agamree
Agamree (vamorolone) is an FDA-approved treatment for Duchenne muscular dystrophy (DMD) to improve ...
Elevidys
Elevidys is a gene therapy for Duchenne muscular dystrophy, that is given as a one-time infusion ...
Duvyzat
Duvyzat (givinostat) is used to treat Duchenne muscular dystrophy (DMD) to delay symptoms and ...
Emflaza
Emflaza (deflazacort) is a corticosteroid medication used to treat a rare genetic disorder called ...
Vyondys 53
Vyondys 53 is used for Duchenne muscular dystrophy (DMD) in children and young adults with a ...
Exondys 51
Exondys 51 is used for Duchenne Muscular Dystrophy (DMD) in children and young adults with a ...
Givinostat
Givinostat (Duvyzat) is used to treat Duchenne muscular dystrophy (DMD) to delay symptoms and ...
Eteplirsen
Eteplirsen is used for Duchenne Muscular Dystrophy (DMD) in children and young adults with a gene ...
Deflazacort
Deflazacort systemic is used for duchenne muscular dystrophy
References
1. (2023) "Product Information. Agamree (vamorolone)." Santhera Pharmaceuticals (US)
More about vamorolone
- Check interactions
- Compare alternatives
- Dosage information
- During pregnancy
- Drug class: glucocorticoids
- En español
Patient resources
Other brands
Professional resources
Other brands
Related treatment guides
Further information
Vamorolone side effects can vary depending on the individual. Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Note: Medication side effects may be underreported. If you are experiencing side effects that are not listed, submit a report to the FDA by following this guide.